The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Oncology

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.22.4.921PMID 12632088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VCaP, a cell-based model system of human prostate cancer.

  2001cited by this paper
• Establishment and characterization of a new human prostatic cancer cell line: DuCaP.

  2001cited by this paper
• Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins.

  2000cited by this paper
• Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

  2000cited by this paper
• Essential role for G proteins in prostate cancer cell growth and signaling.

  2000cited by this paper
• Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor".

  2000cited by this paper
• Differences in the expression and effects of interleukin-1 and -2 on androgen-sensitive and -insensitive human prostate cancer cell lines.

  2000cited by this paper
• Characterization of the role of IL‐6 in the progression of prostate cancer

  1999cited by this paper
• Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells.

  1999cited by this paper
• An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells.

  1999cited by this paper
• Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

  1997cited by this paper
• Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.

  1997cited by this paper
• New EGF‐R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC‐3 and DU‐145

  1997cited by this paper
• Effects of Human Tumor Cell Lines on Local New Bone Formation In Vivo

  1997cited by this paper
• The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease.

  1997cited by this paper
• An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

  1996cited by this paper
• Divergent effect of TGFbeta1 on growth and proteolytic modulation of human prostatic-cancer cell lines.

  1996cited by this paper
• TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

  1996cited by this paper
• Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.

  1996cited by this paper
• TNF‐mediated cytotoxicity and resistance in human prostate cancer cell lines

  1996cited by this paper
• Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines.

  1995cited by this paper
• Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC‐3 prostate cancer cells

  1995cited by this paper
• Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.

  1995cited by this paper
• Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist.

  1995cited by this paper
• Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells.

  1994cited by this paper
• Cancer statistics, 1994

  1994cited by this paper
• EGF receptor in neoplasia and metastasis

  1993cited by this paper
• Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro.

  1993cited by this paper
• Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.

  1993cited by this paper
• Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.

  1992cited by this paper
• Basic fibroblast growth factor in human prostate cancer cells.

  1992cited by this paper
• Role of cyclic AMP and polypeptide growth regulators in growth inhibition by interferon in PC‐3 cells

  1991cited by this paper
• Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.

  1990cited by this paper
• Therapeutic efficacy of recombinant tumor necrosis factor alpha in an experimental model of human prostatic carcinoma.

  1990cited by this paper
• Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line

  1989cited by this paper
• Interleukin-6 immunoreactivity in human tumors.

  1989cited by this paper
• Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas

  1989cited by this paper
• Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.

  1989cited by this paper
• Growth enhancement of transgenic mice expressing human insulin-like growth factor I.

  1988cited by this paper
• The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA.

  1987cited by this paper

• Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target

  2023cites this paper
• The roles of RUNX2 and osteoclasts in regulating expression of steroidogenic enzymes in castration-resistant prostate cancer cells.

  2021cites this paper
• Adipose tissue:Critical contributor to the development of prostate cancer.

  2018cites this paper
• Biology and Pathophysiology of Bone Metastasis in Prostate Cancer

  2017cites this paper
• Nanoparticles-Based Treatment for Bone Metastasis.

  2016cites this paper
• PDGF-D promotes dermal fibroblast invasion in 3-dimensional extracellular matrix via Snail-mediated MT1-MMP upregulation

  2015cites this paper
• The regulatory role of osteoblasts in castration-resistant growth of prostate cancer

  2015cites this paper
• KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

  2015influential citation
• Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies

  2013cites this paper
• Experimental Models of Prostate Cancer Bone Metastasis - Establishment, characterization and imaging of xenograft bone metastasis models -

  2013cites this paper
• Targeting bone-microenvironment-tumour cell interactions : IGF-1 receptor kinase inhibitors

  2012cites this paper
• Advanced Models for Target Validation & Drug Discovery in Prostate Cancer

  2011cites this paper
• Targeting Neuropilin-1 in Prostate Cancer Bone Metastasis

  2011cites this paper
• Epithelial plasticity, cancer stem cells and bone metastasis formation.

  2011cites this paper
• Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.

  2011cites this paper
• Epithelial plasticity, cancer stem cells and bone metastasis formation.

  2011cites this paper
• Demonstration of Cancer Cell Migration Using a Novel Microfluidic Device

  2010cites this paper
• TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

  2009cites this paper
• Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance.

  2007cites this paper
• Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells.

  2007cites this paper
• Interactions of Prostate Cancer Cells to Human Microvascular Endothelial Cells Under Shear Stress Conditions

  2007cites this paper
• Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells.

  2005cites this paper
• Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors.

  2005influential citation
• Prostate Cancer Prevention

  2005cites this paper
• Establishment and characterization of a human primary prostate carcinoma cell line, HH870

  2005cites this paper
• PROSTATE CANCER: MODELS FOR DEVELOPING NOVEL THERAPEUTIC APPROACHES

  2004cites this paper
• Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells.

  2004cites this paper
• The basic biology of metastasis.

  2004cites this paper
• Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate

  2004cites this paper